Paclitaxol Every 2 Week Versus Paclitaxol Every 1 Week in the Adjuvant Treatment of Breast Cancer
NCT01848197
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
1000
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Paclitaxel
Epirubicin
Cyclophosphamide
Interventions
DRUG:
paclitaxel
Sponsor
Taizhou Hospital